WELL Health - apps.healthWELL is connecting healthcare professionals with pioneering apps that integrate with their EMR. Learn More. WELL Health - apps.health

Blog Posts

LD Micro Virtual Interview – WELL Corporate Update with Hamed Shahbazi, Chairman and CEO

A WELL Health Video Update:

Chris Lahiji of LD Micro hosts Interview with Hamed Shahbazi, Chairman & CEO of WELL Health

See the full interview here:

WELL Health Investor Presentation interview image

WELL Health Technologies Corp. (TSX: WELL) (“WELL” or the “Company”), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, is pleased to present this virtual sit-down interview with Chris Lahiji of LD Micro and Hamed Shahbazi, Chairman and CEO of WELL. 

“The smaller a company is, the more important management becomes,” said Chris Lahiji, CEO and Founder of LD Micro. “I believe that our next presenter embodies what every investor large and small looks for in executive leadership.”

In the interview Mr. Shahbazi discusses the Company’s financial performance, revenue growth plan, corporate strategy, long-term vision and acquisition pipeline. Over the past year WELL has acquired 14 companies, made two minority investments, expanded into the US and saw its share price increase by over 400%. 

“We had a very exhilarating 2020,” said Mr. Shahbazi. “It was a very sobering year. It was a year that tested us in every way humanly possible, but we really feel that we delivered for our community.” 

In the interview, Mr. Shahbazi also commented:

“We have ten analysts that cover the story from larger banks to smaller banks – all in Canada today and they have us just over $100 million Canadian this year.  Keep in mind, that we ended the year at a $94 million baseline revenue run-rate.  If you add a little bit of organic growth to that without any acquisitions, you pretty much reach that $100 million. So we are pretty much right on the doorstep of $100 million. We believe we will breakthrough these (consensus) estimates.”

“As a capital allocator it's important that if you want to continue to allocate capital you make some of it - and so these capital allocation stories, these opportunities, these companies - they really thrive when positive cash flow is redirected into acquiring more assets that create more positive cash flow and we believe we're just about to get to the really, really fun part - the really, really compelling part of the WELL Health story.”

Click Here for the video interview

About WELL Health Technologies Corp.

WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. As such, WELL owns and operates 27 primary healthcare clinics, is Canada's third largest digital Electronic Medical Records (EMR) supplier serving approximately 2,200 healthcare clinics, operates a high quality telehealth services in both Canada and the United States and is a provider of digital health, billing and cybersecurity related technology solutions. WELL is an acquisitive company that follows a disciplined and accretive capital allocation strategy. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and was recognized as a TSX Venture 50 Company three years in a row in 2018, 2019 and 2020. To access the Company's telehealth service, visit: tiahealth.com and for corporate information, visit: www.WELL.company.

About LD Micro

LD Micro, a leading data event company, is one of the most well-known and respected brands serving the small and micro-cap space. Chris Lahiji, CEO and founder of LD Micro and his team has done an incredible job of creating a loyal community of investors and issuers. In September 2020, LD Micro was acquired by SRAX (Nasdaq: SRAX), a financial technology company. LD Micro now has access to the largest active base of micro-cap investors in the world at over 2 million and counting.

 

For further information:

Pardeep S. Sangha

Vice President Corporate Strategy and Investor Relations

investor@well.company

604-572-6392